Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
13 studies found for:    "Primary hyperoxaluria type 1"
Show Display Options
Rank Status Study
1 Active, not recruiting Primary Hyperoxaluria Mutation Genotyping
Condition: Primary Hyperoxaluria
Intervention: Genetic: Genetic Analysis
2 Completed Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate
Condition: Primary Hyperoxaluria Type I
Intervention: Drug: Vitamin B 6
3 Recruiting Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria
Condition: Primary Hyperoxaluria
Intervention: Biological: Oxabact OC5 capsules
4 Recruiting Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis
Condition: Primary Hyperoxaluria
Intervention: Biological: Oxalobacter formigenes
5 Completed Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients
Condition: Primary Hyperoxaluria
Interventions: Biological: Oxalobacter formigenes;   Drug: Placebo
6 Withdrawn International Registry for Primary Hyperoxaluria
Conditions: Primary Hyperoxaluria;   Nephrocalcinosis;   Kidney Stones
Intervention:
7 Completed Phase 2/3 Oxabact Study
Condition: Primary Hyperoxaluria
Interventions: Biological: Oxalobacter formigenes;   Drug: Placebo
8 Recruiting Biobank Protocol, Rare Diseases Clinical Research Network
Conditions: Primary Hyperoxaluria;   Dent Disease;   APRT Deficiency;   Cystinuria
Intervention:
9 Recruiting Rare Kidney Stone Consortium Patient Registry
Conditions: Primary Hyperoxaluria;   Dent Disease;   Cystinuria;   APRT Deficiency
Intervention:
10 Withdrawn Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
Condition: Hyperoxaluria
Interventions: Drug: ACEI / Angiotensin converting enzyme inhibitor;   Drug: ARB /Angiotensin Receptor Blocker;   Drug: Placebo
11 Completed
Has Results
Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria
Condition: Hyperoxaluria
Interventions: Drug: Betaine;   Drug: Placebo
12 Recruiting Health-related Quality of Life in Rare Kidney Stone
Conditions: Primary Hyperoxaluria;   Cystinuria;   Adenine Phosphoribosyl Transferase Deficiency;   Dent Disease
Intervention:
13 Recruiting Hydroxyproline Influence on Oxalate Metabolism
Condition: Hyperoxaluria
Intervention: Drug: Hydroxyproline and Leucine

Indicates status has not been verified in more than two years